Raymond J. Henley Iii

Array ( [id] => 4157953 [patent_doc_number] => 06114387 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2000-09-05 [patent_title] => 'Pharmaceutical composition for oral administration of chelating agents' [patent_app_type] => 1 [patent_app_number] => 9/505403 [patent_app_country] => US [patent_app_date] => 2000-02-16 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 1064 [patent_no_of_claims] => 9 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 68 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/114/06114387.pdf [firstpage_image] =>[orig_patent_app_number] => 505403 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4350786 [patent_doc_number] => 06214867 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2001-04-10 [patent_title] => 'Anticonvulsant derivatives useful in treating essential tremor' [patent_app_type] => 1 [patent_app_number] => 9/504151 [patent_app_country] => US [patent_app_date] => 2000-02-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 3883 [patent_no_of_claims] => 10 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 181 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/214/06214867.pdf [firstpage_image] =>[orig_patent_app_number] => 504151 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4090303 [patent_doc_number] => 06133304 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2000-10-17 [patent_title] => 'ACE inhibitor-MMP inhibitor combinations' [patent_app_type] => 1 [patent_app_number] => 9/485253 [patent_app_country] => US [patent_app_date] => 2000-02-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 8 [patent_figures_cnt] => 8 [patent_no_of_words] => 34730 [patent_no_of_claims] => 10 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 28 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/133/06133304.pdf [firstpage_image] =>[orig_patent_app_number] => 485253 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 570139 [patent_doc_number] => 07462643 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2008-12-09 [patent_title] => 'Essential fatty acids in the prevention of cardiovascular events' [patent_app_type] => utility [patent_app_number] => 09/869333 [patent_app_country] => US [patent_app_date] => 2000-02-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 1595 [patent_no_of_claims] => 26 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 92 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/462/07462643.pdf [firstpage_image] =>[orig_patent_app_number] => 09869333 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4360129 [patent_doc_number] => 06255298 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2001-07-03 [patent_title] => 'Macrophage scavenger receptor antagonists for use in the treatment of cardiovascular diseases' [patent_app_type] => 1 [patent_app_number] => 9/463863 [patent_app_country] => US [patent_app_date] => 2000-01-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 3827 [patent_no_of_claims] => 10 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 163 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/255/06255298.pdf [firstpage_image] =>[orig_patent_app_number] => 463863 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4338159 [patent_doc_number] => 06333347 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2001-12-25 [patent_title] => 'Intrapericardial delivery of anti-microtubule agents' [patent_app_type] => 1 [patent_app_number] => 9/493702 [patent_app_country] => US [patent_app_date] => 2000-01-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 10 [patent_figures_cnt] => 15 [patent_no_of_words] => 11688 [patent_no_of_claims] => 6 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 45 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/333/06333347.pdf [firstpage_image] =>[orig_patent_app_number] => 493702 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4185190 [patent_doc_number] => 06150410 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2000-11-21 [patent_title] => 'pH independent extended release pharmaceutical formulation' [patent_app_type] => 1 [patent_app_number] => 9/490531 [patent_app_country] => US [patent_app_date] => 2000-01-25 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 6 [patent_no_of_words] => 5970 [patent_no_of_claims] => 30 [patent_no_of_ind_claims] => 8 [patent_words_short_claim] => 19 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/150/06150410.pdf [firstpage_image] =>[orig_patent_app_number] => 490531 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4240672 [patent_doc_number] => 06136317 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2000-10-24 [patent_title] => 'Chromium picolinate compositions' [patent_app_type] => 1 [patent_app_number] => 9/480472 [patent_app_country] => US [patent_app_date] => 2000-01-10 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 3528 [patent_no_of_claims] => 75 [patent_no_of_ind_claims] => 10 [patent_words_short_claim] => 24 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/136/06136317.pdf [firstpage_image] =>[orig_patent_app_number] => 480472 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4103373 [patent_doc_number] => 06100251 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2000-08-08 [patent_title] => 'Chromium polynicotinate compositions' [patent_app_type] => 1 [patent_app_number] => 9/480473 [patent_app_country] => US [patent_app_date] => 2000-01-10 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 3526 [patent_no_of_claims] => 75 [patent_no_of_ind_claims] => 11 [patent_words_short_claim] => 14 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/100/06100251.pdf [firstpage_image] =>[orig_patent_app_number] => 480473 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4304219 [patent_doc_number] => 06251888 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2001-06-26 [patent_title] => 'Chromium picolinate compositions and uses thereof' [patent_app_type] => 1 [patent_app_number] => 9/480468 [patent_app_country] => US [patent_app_date] => 2000-01-10 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 3365 [patent_no_of_claims] => 49 [patent_no_of_ind_claims] => 20 [patent_words_short_claim] => 31 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/251/06251888.pdf [firstpage_image] =>[orig_patent_app_number] => 480468 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4305347 [patent_doc_number] => 06316001 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2001-11-13 [patent_title] => 'Method for treatment of psoriasis' [patent_app_type] => 1 [patent_app_number] => 9/480745 [patent_app_country] => US [patent_app_date] => 2000-01-10 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 2782 [patent_no_of_claims] => 12 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 65 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/316/06316001.pdf [firstpage_image] =>[orig_patent_app_number] => 480745 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4272141 [patent_doc_number] => 06245776 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2001-06-12 [patent_title] => 'Formulations and methods for treatment of mucosal associated conditions with an immune response modifier' [patent_app_type] => 1 [patent_app_number] => 9/479578 [patent_app_country] => US [patent_app_date] => 2000-01-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 5 [patent_no_of_words] => 9685 [patent_no_of_claims] => 22 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 50 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/245/06245776.pdf [firstpage_image] =>[orig_patent_app_number] => 479578 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4239976 [patent_doc_number] => 06090856 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2000-07-18 [patent_title] => 'Remedies for frequent urination and urinary incontinence' [patent_app_type] => 1 [patent_app_number] => 9/402942 [patent_app_country] => US [patent_app_date] => 2000-01-03 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 2436 [patent_no_of_claims] => 4 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 30 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/090/06090856.pdf [firstpage_image] =>[orig_patent_app_number] => 402942 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1474995 [patent_doc_number] => 06387897 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2002-05-14 [patent_title] => 'Preferentially substituted calcium channel blockers' [patent_app_type] => B1 [patent_app_number] => 09/476927 [patent_app_country] => US [patent_app_date] => 1999-12-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 4 [patent_no_of_words] => 6753 [patent_no_of_claims] => 40 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 112 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/387/06387897.pdf [firstpage_image] =>[orig_patent_app_number] => 09476927 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4409819 [patent_doc_number] => 06310059 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2001-10-30 [patent_title] => 'Fused ring calcium channel blockers' [patent_app_type] => 1 [patent_app_number] => 9/476928 [patent_app_country] => US [patent_app_date] => 1999-12-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 5079 [patent_no_of_claims] => 27 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 231 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/310/06310059.pdf [firstpage_image] =>[orig_patent_app_number] => 476928 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4300120 [patent_doc_number] => 06326034 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2001-12-04 [patent_title] => 'Natural extracted and synthetic antioxidant compositions' [patent_app_type] => 1 [patent_app_number] => 9/469475 [patent_app_country] => US [patent_app_date] => 1999-12-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 27 [patent_figures_cnt] => 27 [patent_no_of_words] => 7342 [patent_no_of_claims] => 9 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 12 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/326/06326034.pdf [firstpage_image] =>[orig_patent_app_number] => 469475 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4237118 [patent_doc_number] => 06165975 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2000-12-26 [patent_title] => 'Microdose therapy' [patent_app_type] => 1 [patent_app_number] => 9/469649 [patent_app_country] => US [patent_app_date] => 1999-12-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 8 [patent_figures_cnt] => 12 [patent_no_of_words] => 10711 [patent_no_of_claims] => 48 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 41 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/165/06165975.pdf [firstpage_image] =>[orig_patent_app_number] => 469649 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1312867 [patent_doc_number] => 06610669 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2003-08-26 [patent_title] => 'Water insoluble derivatives of polyanionic polysaccharides' [patent_app_type] => B1 [patent_app_number] => 09/469638 [patent_app_country] => US [patent_app_date] => 1999-12-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 6765 [patent_no_of_claims] => 23 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 17 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/610/06610669.pdf [firstpage_image] =>[orig_patent_app_number] => 09469638 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1551111 [patent_doc_number] => 06399633 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2002-06-04 [patent_title] => 'Use of 4-H-1-benzopryan-4-one derivatives as inhibitors of smooth muscle cell proliferation' [patent_app_type] => B1 [patent_app_number] => 09/468665 [patent_app_country] => US [patent_app_date] => 1999-12-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 8 [patent_figures_cnt] => 16 [patent_no_of_words] => 8542 [patent_no_of_claims] => 15 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 18 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/399/06399633.pdf [firstpage_image] =>[orig_patent_app_number] => 09468665 [rel_patent_id] =>[rel_patent_doc_number] =>)